Clinical Trial Details

Trial ID: L0486
Source ID: IRCT20161205031252N10
Associated Drug: Dandelion
Title: Effect of dandelion capsule on improvement of liver fibrosis and liver function test among patients with non-alcoholic fatty liver disease
Acronym: --
Status: Recruiting
Study Results: No Results Available
Results: --
Conditions: Condition 1: Nonalcoholic steatohepatitis. Condition 2: Fatty liver. <br>Nonalcoholic steatohepatitis (NASH) <br>Fatty (change of) liver, not elsewhere classified;K75.81
Interventions: Intervention 1: Intervention group: Dandelion capsule, 300 mg, oral, twice a day, for 3 months. Intervention 2: Control group: placebo capsule, oral, twice a day, for 3 months.
Outcome Measures: Liver stiffness. Timepoint: Three months after treatment. Method of measurement: Fibroscan.Blood levels of liver enzymes. Timepoint: Three months after treatment. Method of measurement: Blood test.
Sponsor/Collaborators: Ghoum University of Medical Sciences
Gender: All
Age: 18 years65 years
Phases: Phase 2/Phase 3
Enrollment: 50
Study Type: interventional
Study Designs: Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: The patients will be assigned to two groups of intervention and control by block randomization. For this purpose block
Start Date: 22/11/2018
Completion Date: --
Results First Posted: --
Last Update Posted: 14 January 2019
Locations: Iran (Islamic Republic of)
URL: http://en.irct.ir/trial/35123